- ⚠️《2026年兴奋剂目录》
- 英文名称17α-Methyl-1-Testosterone
- 中文名称17α-甲基异睾酮
- IUPAC名称(5S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-5,6,7,8,9,11,12,14,15,16-decahydro-4H-cyclopenta[a]phenanthren-3-one
- 其它别名17b-Hydroxy-17a-methyl-5a-androst-1-en-3-one
- CAS编号65-04-3
- EINECS号:691-758-7
- FDA UNII编号:21O907N0NH
- 分子式:C20H30O2
- 分子量:302.457
- 产品CID: 2497214
- 产品分类原料药 → 激素及调节内分泌功能类药 → 雄激素及同化激素类药
- 相似结构搜索
- InChIKey: JRNSSSJKIGAFCT-YDSAWKJFSA-N
- 1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,13,15-17,22H,4-5,7-8,10-12H2,1-3H3/t13-,15+,16-,17-,1…
- 计算化学: 氢键受体数2.0氢键供体数1.0可旋转键数0.0
MSDS等安全信息
- GHS象形图

- GHS符号GHS08;
注释: Health hazard - 危险类别生殖毒性 类别2
生殖毒性 类别1A
急性毒性 类别4(吸入)
急性毒性 类别4(经皮)
急性毒性 类别4(经口)
特定目标器官毒性 - 单次接触 类别3
皮肤腐蚀/刺激 类别2
严重眼刺激 类别2 - 警示词Warning(警告)
- 危险描述H361fd |怀疑会影响生育能力. 怀疑对胎儿造成损害.
H360 |可能损害生育能力或胎儿.
H332 |吸入有害.
H312 |皮肤接触有害.
H302 |吞咽有害.
H335 |可能引起呼吸道刺激.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激. - 防范说明P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
- 危险品标志T
- 安全声明53-36/37-45
- 危险类别码R45
- WGK Germany3
欧盟法规
C&L通报上下游产品
2α-bromo-17β-hydroxy-17α-methyl-5α-androstan-3-one (223)C05451ZIN(223)C05451 Epiandrosterone mestanolone oxandrolone 美雄诺龙置于甲烷磺酸,2-Iodoxybenzoic Acid体系中,用 N,N-二甲基乙酰胺,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 13.0H,反应生成 17Alpha-甲基异睾酮
参考文献:一种氧雄龙中间体的制备方法
标题:一种氧雄龙中间体的制备方法
摘要:本发明属于有机合成技术领域.本发明提供了一种17β‑羟基‑17α‑甲基‑1‑氧代‑1,2‑开环‑a失碳‑5α‑雄甾‑2‑含氧羧酸的制备方法,包括如下步骤:1)将美雄诺龙,2‑碘酰基苯甲酸,催化剂和溶剂混合后进行氧化反应,得到化合物1;2)将化合物1,氧化剂水溶液,碳酸氢盐和丙酮混合后进行氧化反应,得到17β‑羟基‑17α‑甲基‑1‑氧代‑1,2‑开环‑a失碳‑5α‑雄甾‑2‑含氧羧酸.本发明的制备方法所得到产品的纯度>=98%,收率为95~97%;本发明的制备方法所需的反应温度低,同时显著缩短了反应时间,产品生产周期短,操作简单,生产成本降低,绿色环保.
海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2905122000-异丙醇
2905143000-叔丁醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-6448413-B1
优先权日:1999-06-10
标题:Process for the synthesis of a-nor-seco compounds with sterane skeleton
发明人:SANTA CSABA; TUBA ZOLTAN; MAHO SANDOR; SZELES JANOS; BALOGH GABOR; BRLIK JANOS; TRISCHLER FERENC; SZILAGYI GABRIELLA; BAKCSI ERIKA
权利人:RICHTER GEDEON VEGYESZET
摘要:The invention relates to a new process for the synthesis of 17β-hydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-3-acid derivatives of formula (I) n wherein the meaning of Z is carboxyl or formyl group and n to the new secoindoxylidene carboxylic acid derivatives of formula (II) n wherein R 1 and R 2 independently are C 1 -C 4 alkyl or alkoxy group, hydrogen or halogen atom—which are intermediates for preparing the compounds of formula (I). n The 17β-hydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-3-acid derivatives of formula (I) are intermediates in the synthesis of oxandrolon (17β-hydroxy-17α-methyl-2-oxa-5α-androstane-3-one), which is used as anabolic in therapy.
专利号:US-6583298-B1
优先权日:1999-06-10
标 题:Process for the synthesis of 17β-hydroxy-17α-methyl-2-oxa-5α-androstane-3-one
发明人:SANTA CSABA; TUBA ZOLTAN; MAHO SANDOR; SZELES JANOS; FERENCZI KATALIN; HORVATH PETER; LANCOS KRISZTINA; MESTER TAMAS; TROMPLER ARPAD
权利人:RICHTER GEDEON VEGYESZET
摘要:The invention relates to a new process for the synthesis of 17β-hydroxy-17α-methyl-2-oxa-5α-androstane-3-one of formula (I). The process according to the invention is as follows: the 17β-hydroxy-17α-ethyl-1,3-seco-2-nor-5α-androstane-1,3-diacid of formula (III) is transformed into the ring-closed 17β-hydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-1,3-diacid anhydride of formula (II) in an inert solvent or without solvent with a C 2 -C 3 alkan acid anhydride or a substituted carbodiimide of formula R 1 —Nâ•?Câ•?N—R 2 — wherein R 1 and R 2 independently are C 1 -C 6 alkyl group, C 1 -C 6 alkyl group substituted by tertiary or quaternary amino group or 1-3 phenyl group, C 5 -C 6 cycloalkyl group, aryl group substituted by 1-3 methoxy, tertiary amino, nitro, C 1 -C 4 alkyl group or 1-3 halogen atom—and the obtained compound of formula (II) is reduced regioselectively by a complex alkali metal hydride in an inert solvent The new 17β-hydroxy-17α-methyl-1,3-seco-2-nor-5α-androstane-1,3-diacid anhydride of ormula (II) is also the subject of the invention.
专利号:US-2003032817-A1
优先权日:2001-05-15
标题:Process for the synthesis of oxandrolone
发明人:CABAJ JOHN E; KAIRYS DAVID L; ZIZELMAN PAUL M
摘要:A process is disclosed for synthesizing oxandrolone 1 involving the bromination of compound 2 to obtain compound 3, followed by the highly selective de-bromination of compound 3 to obtain compound 4, followed by the oxidation of compound 4 to obtain compound 6, and finally the reduction of compound 6 to obtain oxandrolone 1.
专利号:US-7009063-B2
优先权日:2001-12-11
标题:Process for the production of oxandrolone
发明人:DESAI SHAILESHKUMAR RAMANLAL; RAY JR DAVID WAYNE; SAYED YOUSRY A
权利人:BARR LAB INC
摘要:The present invention relates to a process for the synthesis of oxandrolone from mestanolone. The process comprises the steps of: (a) oxidizing mestanolone to form 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one; (b) hydroxylating the 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one to form 1α, 2α, 17β-trihydroxy-17α-methylandrostan-3-one; (c) cleaving the 1α, 2α, 17β-trihydroxy-17α-methylandrostan-3-one to form 17β-hydroxy-17α-methyl-1-oxo-1,2,-seco-A-nor-5α-androstan-2-oic acid; and (d) reducing the 17β-hydroxy-17α-methyl-1-oxo-1,2,-seco-A-nor-5α-androstan-2-oic acid to form oxandrolone.
专利号:EP-1189885-B1
优先权日:1999-06-10
标题:Process for the synthesis of a-nor-seco compounds with sterane skeleton
专利号:WO-02100881-A1
优先权日:2001-05-15
标 题:Process for the synthesis of oxandrolone